(1)
Ninety-Day Outcome of Patients With Severe COVID-19 Treated With Tocilizumab – a Single Centre Cohort Study. Swiss Med Wkly 2021, 151 (3132), w20550. https://doi.org/10.4414/smw.2021.20550.